Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cholelithiasis | 7 | 2018 | 47 | 2.78 | Why? |
| Gallstones | 5 | 2018 | 64 | 2.42 | Why? |
| Bile Acids and Salts | 5 | 2018 | 91 | 2.34 | Why? |
| Cholesterol | 5 | 2018 | 660 | 1.79 | Why? |
| Familial Mediterranean Fever | 2 | 2020 | 88 | 1.41 | Why? |
| Metabolic Syndrome | 5 | 2020 | 810 | 1.40 | Why? |
| Helicobacter Infections | 3 | 2019 | 216 | 1.25 | Why? |
| Helicobacter pylori | 3 | 2019 | 262 | 1.22 | Why? |
| Non-alcoholic Fatty Liver Disease | 7 | 2021 | 907 | 1.21 | Why? |
| Cholecystectomy | 2 | 2018 | 198 | 1.20 | Why? |
| Gallbladder | 4 | 2018 | 58 | 1.19 | Why? |
| Diet | 8 | 2021 | 2052 | 1.06 | Why? |
| Aquaporins | 2 | 2019 | 15 | 0.95 | Why? |
| Esomeprazole | 2 | 2019 | 7 | 0.92 | Why? |
| Pyrin | 1 | 2020 | 15 | 0.88 | Why? |
| Irritable Bowel Syndrome | 2 | 2019 | 175 | 0.77 | Why? |
| Cholagogues and Choleretics | 1 | 2018 | 11 | 0.76 | Why? |
| Bibliotherapy | 1 | 2018 | 15 | 0.76 | Why? |
| Gastrointestinal Transit | 1 | 2018 | 8 | 0.75 | Why? |
| Prunus dulcis | 1 | 2018 | 6 | 0.75 | Why? |
| Biliary Tract | 1 | 2018 | 21 | 0.75 | Why? |
| Ursodeoxycholic Acid | 1 | 2018 | 25 | 0.75 | Why? |
| Cholestasis | 2 | 2018 | 114 | 0.74 | Why? |
| Gastrointestinal Hormones | 1 | 2017 | 7 | 0.73 | Why? |
| Thermogenesis | 1 | 2017 | 14 | 0.73 | Why? |
| Diet Therapy | 1 | 2019 | 66 | 0.73 | Why? |
| Obesity | 7 | 2021 | 7388 | 0.72 | Why? |
| Tetracycline | 1 | 2017 | 33 | 0.70 | Why? |
| Metronidazole | 1 | 2017 | 59 | 0.69 | Why? |
| Food Contamination | 1 | 2019 | 142 | 0.68 | Why? |
| Bismuth | 1 | 2017 | 56 | 0.68 | Why? |
| Functional Food | 1 | 2019 | 122 | 0.68 | Why? |
| Reading | 1 | 2018 | 80 | 0.68 | Why? |
| Enterocolitis | 1 | 2018 | 62 | 0.67 | Why? |
| Ezetimibe | 1 | 2017 | 50 | 0.66 | Why? |
| Intestinal Absorption | 1 | 2017 | 64 | 0.66 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.63 | Why? |
| Colchicine | 2 | 2020 | 730 | 0.62 | Why? |
| Weight Gain | 1 | 2021 | 552 | 0.61 | Why? |
| Proton Pump Inhibitors | 2 | 2019 | 377 | 0.61 | Why? |
| Anticholesteremic Agents | 2 | 2017 | 186 | 0.59 | Why? |
| Liver | 8 | 2020 | 4007 | 0.55 | Why? |
| Inulin | 1 | 2014 | 51 | 0.55 | Why? |
| Endemic Diseases | 1 | 2017 | 480 | 0.50 | Why? |
| Intestinal Mucosa | 2 | 2017 | 1046 | 0.49 | Why? |
| Gastrointestinal Agents | 1 | 2017 | 393 | 0.49 | Why? |
| Environmental Pollutants | 1 | 2017 | 320 | 0.48 | Why? |
| Hydrogen | 1 | 2014 | 195 | 0.48 | Why? |
| Polyphenols | 4 | 2019 | 283 | 0.45 | Why? |
| Colonoscopy | 2 | 2018 | 738 | 0.45 | Why? |
| Family Practice | 1 | 2018 | 472 | 0.44 | Why? |
| Gastrointestinal Microbiome | 6 | 2019 | 1961 | 0.42 | Why? |
| Hepatocytes | 3 | 2019 | 549 | 0.42 | Why? |
| Bariatric Surgery | 2 | 2019 | 1298 | 0.41 | Why? |
| Energy Metabolism | 4 | 2018 | 451 | 0.41 | Why? |
| Exercise | 2 | 2021 | 6771 | 0.39 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.38 | Why? |
| Polyethylene Glycols | 1 | 2014 | 574 | 0.38 | Why? |
| Life Style | 3 | 2018 | 2708 | 0.37 | Why? |
| Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.37 | Why? |
| Respiration | 1 | 2014 | 729 | 0.36 | Why? |
| Epigenesis, Genetic | 3 | 2019 | 711 | 0.34 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.34 | Why? |
| Oxidative Stress | 5 | 2019 | 2050 | 0.33 | Why? |
| Lipid Metabolism | 4 | 2018 | 572 | 0.31 | Why? |
| Adiponectin | 2 | 2017 | 123 | 0.31 | Why? |
| Leptin | 2 | 2017 | 141 | 0.30 | Why? |
| Diet, Mediterranean | 2 | 2021 | 351 | 0.29 | Why? |
| Adiposity | 2 | 2019 | 329 | 0.29 | Why? |
| Adipose Tissue | 3 | 2019 | 612 | 0.28 | Why? |
| Intestines | 4 | 2019 | 817 | 0.28 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.27 | Why? |
| Animals | 20 | 2020 | 78931 | 0.26 | Why? |
| Remission Induction | 2 | 2017 | 950 | 0.26 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.26 | Why? |
| Adipocytes | 2 | 2021 | 173 | 0.25 | Why? |
| Breath Tests | 2 | 2018 | 338 | 0.24 | Why? |
| Drug Administration Schedule | 3 | 2019 | 2324 | 0.23 | Why? |
| Mitochondria | 3 | 2019 | 857 | 0.23 | Why? |
| Lipid Droplets | 2 | 2019 | 75 | 0.23 | Why? |
| Signal Transduction | 5 | 2018 | 7207 | 0.23 | Why? |
| Fibronectins | 1 | 2021 | 92 | 0.22 | Why? |
| Colon | 2 | 2018 | 669 | 0.21 | Why? |
| Humans | 53 | 2021 | 930598 | 0.21 | Why? |
| Lactose Intolerance | 1 | 2019 | 9 | 0.20 | Why? |
| Dietary Proteins | 2 | 2019 | 112 | 0.20 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.20 | Why? |
| Tinidazole | 1 | 2019 | 9 | 0.20 | Why? |
| Lactose | 1 | 2019 | 17 | 0.20 | Why? |
| Colorectal Neoplasms | 1 | 2014 | 1884 | 0.20 | Why? |
| Bifidobacterium longum | 1 | 2019 | 23 | 0.20 | Why? |
| Sensory Thresholds | 1 | 2020 | 115 | 0.20 | Why? |
| Lactobacillus rhamnosus | 1 | 2019 | 23 | 0.20 | Why? |
| Pesticide Residues | 1 | 2019 | 13 | 0.20 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.19 | Why? |
| Capsaicin | 1 | 2018 | 19 | 0.19 | Why? |
| Phthalic Acids | 1 | 2019 | 40 | 0.19 | Why? |
| Biliary Dyskinesia | 1 | 2018 | 1 | 0.19 | Why? |
| Sucrase-Isomaltase Complex | 1 | 2018 | 1 | 0.19 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.19 | Why? |
| Catechols | 1 | 2018 | 43 | 0.19 | Why? |
| Gastric Emptying | 1 | 2018 | 9 | 0.19 | Why? |
| Enterohepatic Circulation | 1 | 2017 | 1 | 0.18 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2018 | 46 | 0.18 | Why? |
| Amoxicillin | 1 | 2019 | 98 | 0.18 | Why? |
| Diiodothyronines | 1 | 2017 | 4 | 0.18 | Why? |
| Clarithromycin | 1 | 2019 | 112 | 0.18 | Why? |
| Cecum | 1 | 2018 | 63 | 0.18 | Why? |
| Bile | 1 | 2018 | 56 | 0.18 | Why? |
| Cholecystokinin | 1 | 2017 | 2 | 0.18 | Why? |
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 67 | 0.17 | Why? |
| Terpenes | 1 | 2018 | 135 | 0.17 | Why? |
| Insulin Resistance | 2 | 2020 | 669 | 0.17 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.17 | Why? |
| Olfactory Perception | 1 | 2018 | 93 | 0.17 | Why? |
| Capsules | 1 | 2017 | 140 | 0.17 | Why? |
| Gene-Environment Interaction | 1 | 2018 | 127 | 0.17 | Why? |
| Gastric Bypass | 1 | 2019 | 152 | 0.17 | Why? |
| European Union | 1 | 2021 | 565 | 0.17 | Why? |
| Tablets | 1 | 2017 | 219 | 0.16 | Why? |
| Phenols | 1 | 2019 | 226 | 0.16 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.16 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2018 | 238 | 0.16 | Why? |
| Inflammation Mediators | 2 | 2018 | 2654 | 0.16 | Why? |
| Italy | 7 | 2021 | 38444 | 0.16 | Why? |
| Tubulin Modulators | 1 | 2017 | 126 | 0.16 | Why? |
| Inflammation | 5 | 2020 | 13255 | 0.16 | Why? |
| Cholecystitis | 1 | 2018 | 141 | 0.16 | Why? |
| Feces | 3 | 2019 | 4235 | 0.15 | Why? |
| Serum Amyloid A Protein | 1 | 2017 | 211 | 0.15 | Why? |
| Hypercholesterolemia | 1 | 2017 | 175 | 0.15 | Why? |
| Benzhydryl Compounds | 1 | 2019 | 240 | 0.15 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.15 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Reactive Oxygen Species | 2 | 2019 | 1136 | 0.15 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.15 | Why? |
| Drug Therapy, Combination | 3 | 2019 | 7268 | 0.14 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.14 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.14 | Why? |
| Fatty Liver | 1 | 2019 | 299 | 0.14 | Why? |
| Overweight | 1 | 2021 | 916 | 0.14 | Why? |
| Proteins | 2 | 2021 | 921 | 0.14 | Why? |
| Muscle Strength | 1 | 2017 | 317 | 0.14 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.14 | Why? |
| Cholesterol, HDL | 1 | 2017 | 439 | 0.14 | Why? |
| Probiotics | 2 | 2019 | 694 | 0.14 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.13 | Why? |
| Internal Medicine | 1 | 2020 | 557 | 0.13 | Why? |
| Risk Factors | 8 | 2020 | 71621 | 0.13 | Why? |
| Metabolome | 1 | 2019 | 624 | 0.13 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.13 | Why? |
| Pulmonary Artery | 1 | 2021 | 803 | 0.13 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.13 | Why? |
| Healthy Lifestyle | 1 | 2018 | 447 | 0.13 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.13 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.12 | Why? |
| Disease Models, Animal | 4 | 2018 | 10998 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Rats | 5 | 2019 | 2764 | 0.11 | Why? |
| Apoptosis | 2 | 2021 | 2335 | 0.11 | Why? |
| Weight Loss | 1 | 2017 | 826 | 0.11 | Why? |
| Surface-Active Agents | 1 | 2014 | 267 | 0.11 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.11 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.11 | Why? |
| Computed Tomography Angiography | 1 | 2021 | 2153 | 0.11 | Why? |
| Celiac Disease | 1 | 2017 | 471 | 0.10 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.10 | Why? |
| Adult | 13 | 2021 | 244371 | 0.10 | Why? |
| Female | 16 | 2021 | 380317 | 0.10 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.10 | Why? |
| Crohn Disease | 1 | 2018 | 959 | 0.10 | Why? |
| Heart | 1 | 2019 | 1791 | 0.10 | Why? |
| Male | 16 | 2021 | 367725 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Athletes | 1 | 2017 | 1047 | 0.09 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.09 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Colitis, Ulcerative | 1 | 2018 | 1037 | 0.09 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.09 | Why? |
| Obesity, Morbid | 1 | 2019 | 1340 | 0.09 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.09 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.09 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.08 | Why? |
| Thioredoxins | 1 | 2007 | 25 | 0.08 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.08 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| Liver Cirrhosis, Biliary | 1 | 2007 | 42 | 0.08 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.08 | Why? |
| Fatty Acids | 2 | 2019 | 238 | 0.08 | Why? |
| Biological Transport | 2 | 2017 | 290 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.08 | Why? |
| Sulfhydryl Compounds | 1 | 2007 | 104 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Cell Line, Tumor | 3 | 2019 | 3608 | 0.07 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.07 | Why? |
| Mice | 3 | 2018 | 21357 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Cardiovascular Diseases | 2 | 2019 | 11497 | 0.06 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.06 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.05 | Why? |
| Lactase | 1 | 2019 | 4 | 0.05 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
| Vitamin B 6 | 1 | 2019 | 18 | 0.05 | Why? |
| Diet, High-Protein | 1 | 2019 | 3 | 0.05 | Why? |
| Pyroptosis | 1 | 2021 | 168 | 0.05 | Why? |
| Elasticity | 1 | 2019 | 70 | 0.05 | Why? |
| Nitric Oxide | 1 | 2007 | 769 | 0.05 | Why? |
| Biophysics | 1 | 2019 | 30 | 0.05 | Why? |
| Fructose | 1 | 2019 | 52 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.05 | Why? |
| Vitamin B Complex | 1 | 2019 | 49 | 0.05 | Why? |
| Prebiotics | 1 | 2019 | 53 | 0.05 | Why? |
| Dietary Fiber | 1 | 2019 | 73 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Bacterial Load | 1 | 2019 | 179 | 0.05 | Why? |
| Eukaryota | 1 | 2018 | 31 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.05 | Why? |
| Dietary Fats | 1 | 2019 | 96 | 0.05 | Why? |
| Biomechanical Phenomena | 1 | 2019 | 291 | 0.05 | Why? |
| Constipation | 1 | 2019 | 99 | 0.04 | Why? |
| Epidemics | 1 | 2019 | 6407 | 0.04 | Why? |
| Mice, Obese | 1 | 2017 | 29 | 0.04 | Why? |
| Receptors, Cholecystokinin | 1 | 2017 | 1 | 0.04 | Why? |
| Gallbladder Emptying | 1 | 2017 | 1 | 0.04 | Why? |
| Gastrectomy | 1 | 2019 | 225 | 0.04 | Why? |
| Infectious Disease Medicine | 1 | 2020 | 311 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2017 | 161 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2019 | 867 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2018 | 88759 | 0.04 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.04 | Why? |
| Biomarkers | 4 | 2020 | 23361 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2019 | 4020 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2014 | 17020 | 0.04 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.03 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.03 | Why? |
| Linear Models | 1 | 2020 | 1914 | 0.03 | Why? |
| Cell Survival | 1 | 2019 | 1581 | 0.03 | Why? |
| Pulmonary Medicine | 1 | 2020 | 706 | 0.03 | Why? |
| Blood Chemical Analysis | 1 | 2017 | 541 | 0.03 | Why? |
| Dysbiosis | 1 | 2019 | 685 | 0.03 | Why? |
| Lipids | 1 | 2019 | 1079 | 0.03 | Why? |
| Dyslipidemias | 1 | 2019 | 791 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Self Report | 1 | 2020 | 3802 | 0.02 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.02 | Why? |
| Nitrogen Compounds | 1 | 2007 | 1 | 0.02 | Why? |
| Hyperglycemia | 1 | 2019 | 1363 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Hyaluronic Acid | 1 | 2007 | 168 | 0.02 | Why? |
| Rats, Wistar | 1 | 2007 | 621 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.01 | Why? |
| Erythrocytes | 1 | 2007 | 617 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Case-Control Studies | 1 | 2007 | 17671 | 0.01 | Why? |